Genome Research in African American Scleroderma Patients (GRASP Study)
- Study HIC#:2000027458
- Last Updated:12/22/2022
The goal of the GRASP Study (Genome Research in African American Scleroderma Patients is to better understand how African American patients are affected by scleroderma. The Yale Scleroderma Program has partnered with Johns Hopkins University and the National Human Genome Research Institute to collect clinical data and blood samples from African American patients diagnosed with scleroderma to achieve this goal.
- Age18 years and older
For more information about this study, including how to volunteer, contact:
- Phone Number: 1-203-737-5571
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact email@example.com, or call +18779788343 for more information.
African American patient with Scleroderma/Systemic sclerosis